Antipsychotic medication for women with schizophrenia spectrum disorders - CORRIGENDUM.

Brand, Bodyl A; Haveman, Yudith R A; de Beer, Franciska; de Boer, Janna N; Dazzan, Paola; Sommer, Iris E C

Brand, Bodyl A; Haveman, Yudith R A; de Beer, Franciska; de Boer, Janna N; Dazzan, Paola; Sommer, Iris E C.

Afiliação

Brand BA; Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Haveman YRA; Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
de Beer F; Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
de Boer JN; Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Dazzan P; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Sommer IEC; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Psychol Med ; 53(10): 4832, 2023 07.

Article em En | MEDLINE | ID: mdl-37161895

Assuntos

Antipsicóticos; Esquizofrenia; Humanos; Feminino; Antipsicóticos/uso terapêutico; Esquizofrenia/tratamento farmacológico; Psicologia do Esquizofrênico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Limite: Female / Humans Idioma: En Revista: Psychol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google